Edwards Lifesciences Corp
EW · XNYSCIK 1099800fmd_0SA1AAKESGG9EB4GWBDR5Y4S58Manufacturing · Orthopedic, Prosthetic & Surgical Appliances & SuppliesTemplate: Standard
Coverage: Jan 01, 2008 to Sep 30, 2026, 72 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 2,964 | 3,435 | 3,723 | 4,348 | 4,386 | 5,233 | 4,464 | 5,010 | 5,440 | 6,068 |
| Cost of revenue | 797 | 875 | 939 | 1,114 | 1,081 | 1,249 | 724 | 978 | 1,118 | 1,334 |
| Net interest income | – | – | (30) | – | – | – | – | (18) | (20) | (20) |
| Gross profit | 2,166 | 2,560 | 2,783 | 3,234 | 3,306 | 3,984 | 3,740 | 4,032 | 4,322 | 4,733 |
| Realized investment gains (losses) | – | – | – | – | 21 | 37 | (52) | (0) | 5 | – |
| Research and development | 442 | 553 | 622 | 753 | 761 | 903 | 844 | 963 | 1,053 | 1,079 |
| Selling, general and administrative | 905 | 991 | 1,089 | 1,242 | 1,228 | 1,494 | 1,358 | 1,583 | 1,789 | 2,085 |
| Operating income | 751 | 1,089 | 748 | 1,147 | 898 | 1,690 | 1,498 | 1,309 | 1,379 | 1,264 |
| Interest expense | 19 | 23 | 30 | 21 | 16 | 18 | 19 | 18 | 20 | 20 |
| Interest and investment income | 11 | 20 | 32 | 32 | 23 | 17 | 36 | 67 | 120 | 169 |
| Other non-operating income (expense) | (5) | (1) | 4 | 8 | 12 | 13 | 21 | 64 | 169 | 9 |
| Income before taxes | 738 | 1,035 | 761 | 1,167 | 917 | 1,702 | 1,520 | 1,372 | 1,548 | 1,273 |
| Income tax expense | 168 | 451 | 39 | 120 | 93 | 199 | 196 | 152 | 152 | 217 |
| Net income from continuing operations | 570 | 584 | 722 | 1,047 | 823 | 1,503 | 1,324 | 1,220 | 1,396 | 1,056 |
| Net income | – | – | – | – | – | 1,503 | 1,522 | 1,402 | 4,175 | 1,074 |
| Net income to common shareholders | 570 | 584 | 722 | 1,047 | 823 | 1,503 | 1,522 | 1,402 | – | – |